Under this grant, apoQlar will supply a total of 30 advanced MR and VR devices. These state-of-the-art devices will be integrated with the HoloMedicine® Platform, a cutting-edge digital solution designed to transform preoperative surgical planning and improve educational outcomes for medical students.
The integration of the HoloMedicine® Platform aims to incorporate digital solutions into 20% of surgical preoperative procedures. By leveraging the power of mixed reality, this initiative will allow surgeons to visualize and plan complex surgeries with unprecedented clarity. The platform provides 3D visualization of patient-specific anatomy, enabling surgeons to rehearse and strategize their approach, ultimately helping enhancing patient safety, reducing surgical risks, and improving postoperative outcomes.
In addition to its clinical applications, the HoloMedicine® Platform will play a crucial role in medical education. The initiative is expected to significantly increase student engagement and knowledge retention by providing immersive, interactive learning experiences. Medical students and residents will benefit from digital training sessions, real-time surgical broadcasts, and access to virtual teaching aids, such as 3D models and videos. These innovative educational tools are designed to provide clearer, more engaging instruction, thus better preparing the next generation of healthcare professionals.
“This grant represents a milestone in our mission to enhance healthcare through innovative technology,” said Sirko Pelzl, CEO of apoQlar. “We are excited to collaborate with the ICS and leverage our HoloMedicine® Platform to improve both surgical outcomes and medical education. This project underscores our commitment to delivering advanced digital health solutions that make a real difference in patient care and professional training.”
The implementation of the HoloMedicine® Platform will be supported by a comprehensive training program for healthcare professionals and technical support. The goal is to ensure seamless integration and maximize the benefits of this groundbreaking technology across the Northern Metropolitan Territorial Management’s facilities.
apoQlar medical is at the forefront of medical mixed reality innovation, providing solutions that transform healthcare delivery, training and education. The company’s flagship HoloMedicine® Platform is utilized worldwide to enhance surgical planning, patient care and professional training through advanced VR and MR technologies.
For more information about apoQlar medical and its innovative solutions, visit http://www.apoQlar.com
Located in Badalona, Spain, Hospital Universitari Germans Trias i Pujol (HUGTiP) is a premier tertiary care institution known for its excellence in healthcare, research, and education. As the referral center for over 800,000 residents of Barcelonès Nord and Maresme, HUGTiP offers a comprehensive range of medical services, including highly specialized treatments and complex surgical procedures. The hospital is equipped with 775 beds and 21 state-of-the-art operating rooms. Situated in the renowned Can Ruti Campus, HUGTiP is a hub of biomedical innovation, fostering collaboration and advancements in the medical field.
The Northern Metropolitan Territorial Management (NMTM) of the Catalan Health Institute (ICS) oversees healthcare services for over 1.4 million residents across Vallès Occidental, Vallès Oriental, Barcelonès Nord, and Maresme. It includes three primary care services and the Germans Trias i Pujol University Hospital, ensuring comprehensive and high-quality medical care and advanced healthcare solutions in the region.
Contact:
Sirko Pelzl, CEO
apoQlar
info@apoqlar.com
+49 40 241 927 79
